e.g. mhealth
Search Results (1 to 9 of 9 Results)
Download search results: CSV END BibTex RIS
Skip search results from other journals and go to results- 2 JMIR Formative Research
- 2 JMIR Public Health and Surveillance
- 2 JMIR Rehabilitation and Assistive Technologies
- 1 JMIR Pediatrics and Parenting
- 1 JMIR Research Protocols
- 1 Journal of Medical Internet Research
- 0 Medicine 2.0
- 0 Interactive Journal of Medical Research
- 0 iProceedings
- 0 JMIR Human Factors
- 0 JMIR Medical Informatics
- 0 JMIR mHealth and uHealth
- 0 JMIR Serious Games
- 0 JMIR Mental Health
- 0 JMIR Preprints
- 0 JMIR Bioinformatics and Biotechnology
- 0 JMIR Medical Education
- 0 JMIR Cancer
- 0 JMIR Challenges
- 0 JMIR Diabetes
- 0 JMIR Biomedical Engineering
- 0 JMIR Data
- 0 JMIR Cardio
- 0 Journal of Participatory Medicine
- 0 JMIR Dermatology
- 0 JMIR Aging
- 0 JMIR Perioperative Medicine
- 0 JMIR Nursing
- 0 JMIRx Med
- 0 JMIRx Bio
- 0 JMIR Infodemiology
- 0 Transfer Hub (manuscript eXchange)
- 0 JMIR AI
- 0 JMIR Neurotechnology
- 0 Asian/Pacific Island Nursing Journal
- 0 Online Journal of Public Health Informatics
- 0 JMIR XR and Spatial Computing (JMXR)

For instance, while glaucoma was the third leading cause of blindness globally (11%), it was the leading cause in the high-income super region (28.2%) [1].
Another target set in the World Health Organization (WHO) Global Action Plan was a focus on the elimination of avoidable blindness within the area of child health [3]. Childhood blindness can either be classified descriptively or etiologically by underlying cause [4].
JMIR Form Res 2025;9:e64986
Download Citation: END BibTex RIS

Diabetic retinopathy (DR) is a leading cause of vision loss and blindness in the United States [1]. Routine eye examinations facilitate early detection and prevent vision loss, as DR is asymptomatic in early stages [2]. The prevalence of DR among people with diabetes was approximately 26% in 2021 [3]. Despite its high prevalence, less than 50% of individuals with diabetes in the United States undergo the recommended annual DR screening [4].
JMIR Form Res 2025;9:e65893
Download Citation: END BibTex RIS

A total of 7 participants with severe to profound intellectual disability and blindness were involved in the study.
The participants were 6 men and 1 woman, who represented a convenience sample [40], shared the same difficulties in orienting and traveling in indoor areas (eg, in finding room destinations, see below), and attended rehabilitation and care centers.
JMIR Rehabil Assist Technol 2024;11:e65680
Download Citation: END BibTex RIS

Retinopathy of prematurity (ROP) is a retinal vasoproliferative disease that occurs in premature and low-birth-weight infants and is the most common cause of blindness and low vision in infants [1,2]. Early detection and treatment are essential for preventing irreversible visual impairment and blindness. The main pathophysiological factor in ROP is an imbalance between proangiogenic and antiangiogenic factors released locally in the retina, resulting in abnormal neovascularization [3].
JMIR Pediatr Parent 2024;7:e60330
Download Citation: END BibTex RIS

Anti–vascular endothelial growth factors (VEGFs) have demonstrated remarkable efficacy in averting blindness, converting once unavoidably blinding conditions into chronic diseases [1]. Anti-VEGFs are currently suggested as the primary treatment for exudative AMD [2], and 5 anti-VEGF agents (ie, ranibizumab, aflibercept, brolucizumab, bevacizumab, and faricimab) are clinically accessible.
JMIR Public Health Surveill 2023;9:e49852
Download Citation: END BibTex RIS

Vision loss and blindness affect approximately 7.08 million Americans and cost the US economy US $134 billion per year [1,2]. Improving and targeting public health and medical interventions to reduce this burden depend on measuring changes in vision loss and blindness prevalence over time at the national, state, and local level.
JMIR Public Health Surveill 2023;9:e44552
Download Citation: END BibTex RIS

Reference 22: Estimates of incidence and prevalence of visual impairment, low vision, and blindness inblindness
JMIR Rehabil Assist Technol 2022;9(4):e42923
Download Citation: END BibTex RIS

Diabetic retinopathy is the primary vision complication caused by diabetes [3] and is the leading cause of new cases of blindness in adults aged 20 to 65 years [4]. The prevalence of diabetic retinopathy in Canada ranges from 20% to 30% [4]. Over a million people from Ontario were affected by diabetic retinopathy in 2016 [5].
JMIR Res Protoc 2021;10(3):e23492
Download Citation: END BibTex RIS

Inherited retinal diseases are the most common causes of severe visual impairment registration among working adults in England and Wales, whereas globally, 60% of blindness among infants is due to genetic diseases [15,16].
To fill this void, we are developing a new web-based resource for these conditions with information written in 2 formats: one using more lay terms for patients and families, while the other has more technical details tailored toward health care professionals.
J Med Internet Res 2021;23(1):e19151
Download Citation: END BibTex RIS